Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting ₹713.61 crore quarterly net profit.
Approved ₹500 crore additional investment in wholly-owned subsidiary Mankind Medicare and realignment of security cover for existing NCDs.
Reappointed Satish Kumar Sharma as Whole-Time Director for 5 years and noted resignation of Global CIO Pramod Gokhale effective May 31, 2026.
Executive directors voluntarily waived commission for FY2025-26 to strengthen cash position for business expansion.